一个诊断评分系统,用于区分良性和恶性囊性卵巢瘤,利用成像功能和生物标志物
Xiaozhong Zheng1, Yunzhi Zhao2, Anqi Wu3
1Department of Radiology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
一个新的评分系统有效地区分了恶性囊性卵巢瘤 (MCOT) 和良性囊性卵巢瘤 (BCOT). 它使用CA125水平和成像功能进行可靠的诊断.
科学领域:
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
- 生物标志物 生物标志物
背景情况:
- 区分恶性囊性卵巢瘤 (MCOT) 和良性囊性卵巢瘤 (BCOT) 对于患者管理至关重要.
- 目前的诊断方法可能缺乏足够的准确性,需要改进的工具.
研究的目的:
- 开发和验证用于区分MCOT和BCOT的诊断评分系统.
- 确定MCOT诊断的关键临床,生物标志物和成像预测因素.
主要方法:
- 一项回顾性研究涉及159名病理确诊的卵巢瘤患者.
- 数据包括临床特征,生物标志物 (例如,CA125) 和来自MRI/CT的16种成像特征.
- 使用多变量逻辑回归来识别预测因素并构建加权评分系统.
主要成果:
- 评分系统包括CA125,纹理,隔膜厚度和增强度.
- 该系统达到0.956的AUC,显示出高的诊断准确度.
- 截止值为6.5点,为MCOT检测提供了86.6%的灵敏度和91.4%的特异性.
结论:
- 开发的评分系统是区分MCOT和BCOT的可靠和方便的工具.
- 关键指标包括CA125升高,囊性固体成分,隔膜厚度≥4毫米,以及中度/突出增强.
更多相关视频
10:35An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
05:42Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation
Published on: October 25, 2024
相关概念视频
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
